Cargando…
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Alzheimer’s disease (AD) is a devastating age-related neurodegenerative disorder with an alarming increasing prevalence. Except for the recently FDA-approved Aducanumab of which the therapeutic effect is not yet conclusively proven, only symptomatic medication that is effective for some AD patients...
Autores principales: | Xie, Junhua, Van Hoecke, Lien, Vandenbroucke, Roosmarijn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770958/ https://www.ncbi.nlm.nih.gov/pubmed/35069578 http://dx.doi.org/10.3389/fimmu.2021.796867 |
Ejemplares similares
-
Low-grade peripheral inflammation affects brain pathology in the App(NL-G-F)mouse model of Alzheimer’s disease
por: Xie, Junhua, et al.
Publicado: (2021) -
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
por: De Vlieger, Lize, et al.
Publicado: (2022) -
Anti-Inflammatory Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Pathology in Niemann–Pick Type C Disease
por: Van Hoecke, Lien, et al.
Publicado: (2021) -
Helicobacter pylori‐derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3‐C3aR signalling
por: Xie, Junhua, et al.
Publicado: (2023) -
Involvement of the Choroid Plexus in the Pathogenesis of Niemann-Pick Disease Type C
por: Van Hoecke, Lien, et al.
Publicado: (2021)